Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Yu Yong. Director active across 1 company, notably GENELUX CORP. Aggregated, 17 reports have been recorded. Breakdown: 1 buy · 8 sells. Total volume traded: €2.1m. History available since 18 August 2023. The latest transaction was filed on 12 May 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations 17 total
▼ VP, Clinical Trial Operations · Executives · 12 May 2025 · GENELUX CORP 5,579 shares @ US$2.92 0.7% of flow Common Stock SEC:0001415889-25-012807:0
◆ VP, Clinical Trial Operations · Executives · 14 Mar 2025 · GENELUX CORP 13,350 shares 0Common Stock SEC:0001415889-25-010879:0
◆ VP, Clinical Trial Operations · Executives · 18 Dec 2024 · GENELUX CORP 29,000 shares 0Common Stock SEC:0001415889-24-030005:0
◆ VP, Clinical Trial Operations · Executives · 19 Feb 2024 · GENELUX CORP 3,661 shares 0Common Stock SEC:0001415889-24-019343:0
▲ VP, Clinical Trial Operations · Executives · 29 May 2024 · GENELUX CORP 2,500 shares Common Stock SEC:0001415889-24-016101:0
Ideal exit: 23 Feb 2025 (T+270) ▼ VP, Clinical Trial Operations · Executives · 15 Dec 2023 · GENELUX CORP 26,732 shares @ US$12.9401 14.1% of flow Common Stock SEC:0001209191-23-058954:0
▼ VP, Clinical Trial Operations · Executives · 7 Dec 2023 · GENELUX CORP 36,800 shares @ US$11.8477 18.1% of flow Common Stock SEC:0001209191-23-057975:0
▼ VP, Clinical Trial Operations · Executives · 21 Nov 2023 · GENELUX CORP 18,665 shares @ US$10.2628 7.8% of flow Common Stock SEC:0001209191-23-056455:0
▼ VP, Clinical Trial Operations · Executives · 17 Nov 2023 · GENELUX CORP 3,541 shares @ US$13.0386 1.9% of flow Common Stock SEC:0001209191-23-056237:0
◇ VP, Clinical Trial Operations · Executives · 24 Oct 2023 · GENELUX CORP 5,200 shares @ US$6.00 1.3% of flow Common Stock SEC:0001209191-23-053554:0
◇ VP, Clinical Trial Operations · Executives · 10 Oct 2023 · GENELUX CORP 5,200 shares @ US$6.00 1.3% of flow Common Stock SEC:0001209191-23-052621:0
◇ VP, Clinical Trial Operations · Executives · 26 Sept 2023 · GENELUX CORP 5,200 shares @ US$6.00 2.4% of flow Common Stock SEC:0001209191-23-050643:0
◇ VP, Clinical Trial Operations · Executives · 20 Sept 2023 · GENELUX CORP 6,000 shares @ US$6.00 2.6% of flow Common Stock SEC:0001209191-23-050282:0
◇ VP, Clinical Trial Operations · Executives · 15 Sept 2023 · GENELUX CORP 10,400 shares @ US$6.00 3.9% of flow Common Stock SEC:0001209191-23-049841:0
▼ VP, Clinical Trial Operations · Executives · 13 Sept 2023 · GENELUX CORP 29,800 shares @ US$21.1385 26.2% of flow Common Stock SEC:0001209191-23-049673:0
▼ VP, Clinical Trial Operations · Executives · 30 Aug 2023 · GENELUX CORP 19,800 shares @ US$24.70 20.0% of flow Common Stock SEC:0001209191-23-047784:0
▼ VP, Clinical Trial Operations · Executives · 18 Aug 2023 · GENELUX CORP 3,265 shares @ US$23.73 3.2% of flow Common Stock SEC:0001209191-23-046879:0